Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 199.65
+9.50 (5.00%)
At close: Aug 17, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 9.64 billion as of August 17, 2026. Its market cap has increased by 26.92% in one year.
Market Cap
9.64B
Enterprise Value
11.16B
Revenue
7.00B
Ranking
n/a
PE Ratio
38.59
Stock Price
199.65
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 9.64B, an increase of 1,585.35%. That is a compound annual growth rate of 12.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 9.64B | 33.19% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 14.30B |
| Syncom Formulations (India) | 14.02B |
| Fermenta Biotech | 12.88B |
| Lincoln Pharmaceuticals | 12.28B |
| Bharat Parenterals | 9.30B |
| Wanbury | 9.13B |
| Sudarshan Pharma Industries | 8.74B |
| Hexagon Nutrition | 7.86B |